Dicer and microRNA expression in multiple sclerosis and response to interferon therapy

Journal of Neuroimmunology

Volumn 292, Issue , 2016, Pages 68-78

  Magner, William J ^a,b   Weinstock Guttman, Bianca ^b,c   Rho, Mina ^d   Hojnacki, David ^b,c   Ghazi, Rabia ^b,c   Ramanathan, Murali ^b,c   Tomasi, Thomas B ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c JACOBS NEUROLOGICAL INSTITUTE   (United States)

^d Hanyang University   (South Korea)

Author keywords

Biomarkers; Dicer; Interferon; MicroRNA; Multiple sclerosis; Therapy

Indexed keywords

BETA1 INTERFERON; DICER; MESSENGER RNA; MICRORNA; MICRORNA 27A; MICRORNA 323; MICRORNA 3614; MICRORNA 494; MYXOVIRUS RESISTANCE PROTEIN A; STAT1 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BETA1A INTERFERON; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; RIBONUCLEASE III;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DRUG RESPONSE; EXPANDED DISABILITY STATUS SCALE; FALSE POSITIVE RESULT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RELIABILITY; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; DISABILITY; METABOLISM; NONPARAMETRIC TEST; STATISTICS;

ADULT; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; DEAD-BOX RNA HELICASES; DISABILITY EVALUATION; FEMALE; HUMANS; INTERFERON BETA-1A; MALE; MICRORNAS; MIDDLE AGED; MULTIPLE SCLEROSIS; RIBONUCLEASE III; RNA, MESSENGER; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC;

EID: 84960852513     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2016.01.009     Document Type: Article

References (88)

1. Angerstein C., Hecker M., Paap B.K., Koczan D., Thamilarasan M., Thiesen H.J., Zettl U.K. Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis. Mol. Neurobiol. 2012, 45:520-535.
2. Asada S., Takahashi T., Isodono K., Adachi A., Imoto H., Ogata T., Ueyama T., Matsubara H., Oh H. Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2512-H2521.
3. Asirvatham A., Gregorie C., Hu Z., Magner W.J., Tomasi T.B. MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol. Immunol. 2008, 45:1995-2006.
4. Aung L.L., Balashov K.E. Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis. Mult Scler J. 2014, 21:1131-1138.
5. Baltimore D., Boldin M.P., O'Connell R.M., Rao D.S., Taganov K.D. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 2008, 9:839-845.
6. Best M.G., Sol N., Kooi I., Tannous J., Westerman B.A., Rustenburg F., Schellen P., Verschueren H., Post E., Koster J., Ylstra B., Ameziane N., Dorsman J., Smit E.F., Verheul H.M., Noske D.P., Reijneveld J.C., Nilsson R.J., Tannous B.A., Wesseling P., Wurdinger T. RNA-seq of tumor-educated platelets enables blood-based Pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell 2015, 28:666-676.
7. Bremer J., O'Connor T., Tiberi C., Rehrauer H., Weis J., Aguzzi A. Ablation of dicer from murine Schwann cells increases their proliferation while blocking myelination. PLoS One 2010, 5.
8. Brown B.D., Naldini L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat. Rev. Genet. 2009, 10:578-585.
9. Castanotto D., Lingeman R., Riggs A.D., Rossi J.J. CRM1 mediates nuclear-cytoplasmic shuttling of mature microRNAs. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21655-21659.
10. Chavali S., Bruhn S., Tiemann K., Saetrom P., Barrenas F., Saito T., Kanduri K., Wang H., Benson M. MicroRNAs act complementarily to regulate disease-related mRNA modules in human diseases. RNA 2013, 19:1552-1562.
11. Cobb B.S., Hertweck A., Smith J., O'Connor E., Graf D., Cook T., Smale S.T., Sakaguchi S., Livesey F.J., Fisher A.G., Merkenschlager M. A role for Dicer in immune regulation. J. Exp. Med. 2006, 203:2519-2527.
12. De Santis G., Ferracin M., Biondani A., Caniatti L., Tola M.R., Castellazzi M., Zagatti B., Battistini L., Borsellino G., Fainardi E., Gavioli R., Negrini M., Furlan R., Granieri E. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J. Neuroimmunol. 2010, 226:165-171.
13. Di Leva G., Croce C.M. miRNA profiling of cancer. Curr. Opin. Genet. Dev. 2013, 23:3-11.
14. Divekar A.A., Dubey S., Gangalum P.R., Singh R.R. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J. Immunol. 2011, 186:924-930.
15. Dugas J.C., Cuellar T.L., Scholze A., Ason B., Ibrahim A., Emery B., Zamanian J.L., Foo L.C., McManus M.T., Barres B.A. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 2010, 65:597-611.
16. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk - database: prediction of possible miRNA binding sites by "walking" the genes of 3 genomes. J. Biomed. Inform. 2011, 44:839-837.
17. Emde A., Eitan C., Liou L.L., Libby R.T., Rivkin N., Magen I., Reichenstein I., Oppenheim H., Eilam R., Silvestroni A., Alajajian B., Ben-Dov I.Z., Aebischer J., Savidor A., Levin Y., Sons R., Hammond S.M., Ravits J.M., Möller T., Hornstein E. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. EMBO J. 2016, (Sep 1. pii: e201490493., Epub ahead of print).
18. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
19. Fenoglio C., Ridolfi E., Cantoni C., De Riz M., Bonsi R., Serpente M., Villa C., Pietroboni A.M., Naismith R.T., Alvarez E., Parks B.J., Bresolin N., Cross A.H., Piccio L.M., Galimberti D., Scarpini E. Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Mult. Scler. 2013, 19:1938-1942.
20. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
21. Gandhi R., Healy B., Gholipour T., Egorova S., Musallam A., Hussain M.S., Nejad P., Patel B., Hei H., Khoury S., Quintana F., Kivisakk P., Chitnis T., Weiner H.L. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann. Neurol. 2013, 73:729-740.
22. Gantier M.P., McCoy C.E., Rusinova I., Saulep D., Wang D., Xu D., Irving A.T., Behlke M.A., Hertzog P.J., Mackay F., Williams B.R. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 2011, 39:5692-5703.
23. García-López J., del Mazo J. Expression dynamics of microRNA biogenesis during preimplantation mouse development. Biochim. Biophys. Acta 2012, 1819:847-854.
24. Gascon E., Gao F.B. Cause or effect: misregulation of microRNA pathways in neurodegeneration. Front. Neurosci. 2012, 6:48.
25. Gibbings D., Mostowy S., Jay F., Schwab Y., Cossart P., Voinnet O. Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat. Cell Biol. 2012, 14:1314-1321.
26. Gokey N.G., Srinivasan R., Lopez-Anido C., Krueger C., Svaren J. Developmental regulation of microRNA expression in Schwann cells. Mol. Cell. Biol. 2012, 32:558-568.
27. González-González E., López-Casas P.P., del Mazo J. The expression patterns of genes involved in the RNAi pathways are tissue-dependent and differ in the germ and somatic cells of mouse testis. Biochim. Biophys. Acta 2008, 1779:306-311.
28. Guerau-de-Arellano M., Smith K.M., Godlewski J., Liu Y., Winger R., Lawler S.E., Whitacre C.C., Racke M.K., Lovett-Racke A.E. Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain 2011, 134:3578-3589.
29. Guerau-de-Arellano M., Alder H., Ozer H.G., Lovett-Racke A., Racke M.K. miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing. J. Neuroimmunol. 2012, 248:32-39.
30. Ha T.Y. MicroRNAs in human diseases: liver and kidney diseases to infectious disease, sickle cell disease and endometrium disease. Immune Netw. 2011, 11:309-323.
31. Hackenberg M., Sturm M., Langenberger D., Falcon-Perez J.M., Aransay A.M. miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Res. 2009, 37:W68-W76.
32. Hamaya Y., Kuriyama S., Takai T., Yoshida K., Yamada T., Sugimoto M., Osawa S., Sugimoto K., Miyajima H., Kanaoka S. A distinct expression pattern of the long 3'-untranslated region dicer mRNA and its implications for posttranscriptional regulation in colorectal cancer. Clin. Transl. Gastroenterol. 2012, 3.
33. Hébert S.S., Papadopoulou A.S., Smith P., Galas M.C., Planel E., Silahtaroglu A.N., Sergeant N., Buee L., De Strooper B. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum. Mol. Genet. 2010, 19:3959-3969.
34. Hecker M., Thamilarasan M., Koczan D., Schroder I., Flechtner K., Freiesleben S., Fullen G., Thiesen H.J., Zettl U.K. MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients. Int. J. Mol. Sci. 2013, 14:16087-16110.
35. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
36. Irvin-Wilson C.V., Chaudhuri G. Alternative initiation and splicing in dicer gene expression in human breast cells. Breast Cancer Res. 2005, 7:R563-R569.
37. Jafari N., Shaghaghi H., Mahmoodi D., Shirzad Z., Alibeiki F., Bohlooli S., Dogaheh H.P. Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients. J. Clin. Neurosci. 2015, 22:200-203.
38. Jakymiw A., Patel R.S., Deming N., Bhattacharyya I., Shah P., Lamont R.J., Stewart C.M., Cohen D.M., Chan E.K. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 2010, 49:549-559.
39. Jernås M., Malmeström C., Axelsson M., Nookaew I., Lycke J., Olsson B. MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol. 2013, 14:32.
40. Junker A. Pathophysiology of translational regulation by microRNAs in multiple sclerosis. FEBS Lett. 2011, 585:3738-3746.
41. Junker A., Krumbholz M., Eisele S., Mohan H., Augstein F., Bittner R., Lassmann H., Wekerle H., Hohlfeld R., Meinl E. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009, 132:3342-3352.
42. Karube Y., Tanaka H., Osada H., Tomida S., Tatematsu Y., Yanagisawa K., Yatabe Y., Takamizawa J., Miyoshi S., Mitsudomi T., Takahashi T. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 2005, 96:111-115.
43. Keller A., Leidinger P., Lange J., Borries A., Schroers H., Scheffler M., Lenhof H.P., Ruprecht K., Meese E. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS ONE 2009, 4.
44. Keller A., Leidinger P., Steinmeyer F., Stahler C., Franke A., Hemmrich-Stanisak G., Kappel A., Wright I., Dorr J., Paul F., Diem R., Tocariu-Krick B., Meder B., Backes C., Meese E., Ruprecht K. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult. Scler. 2014, 20:295-303.
45. Kim S., Lee J.H., Nam S.I. Dicer Is down-regulated and correlated with Drosha in idiopathic sudden sensorineural hearing loss. J. Korean Med. Sci. 2015, 30:1183-1138.
46. Kosaka N., Iguchi H., Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010, 101:2087-2092.
47. Koscianska E., Starega-Roslan J., Krzyzosiak W.J. The role of Dicer protein partners in the processing of microRNA precursors. PLoS ONE 2011, 6.
48. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
49. Krieger S., Sorrells S.F., Nickerson M., Pace T.W. Mechanistic insights into corticosteroids in multiple sclerosis: war horse or chameleon?. Clin. Neurol. Neurosurg. 2014, 119:6-16.
50. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Pena J., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
51. Lattanzi A., Gentner B., Corno D., Di Tomaso T., Mestdagh P., Speleman F., Naldini L., Gritti A. Dynamic activity of miR-125b and miR-93 during murine neural stem cell differentiation in vitro and in the subventricular zone neurogenic niche. PLoS ONE 2013, 8.
52. Le M.T., Xie H., Zhou B., Chia P.H., Rizk P., Um M., Udolph G., Yang H., Lim B., Lodish H.F. MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol. Cell. Biol. 2009, 29:5290-5305.
53. Li J.S., Yao Z.X. MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases. Mol. Neurobiol. 2012, 45:200-212.
54. Lindberg R.L., Hoffmann F., Mehling M., Kuhle J., Kappos L. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur. J. Immunol. 2010, 40:888-898.
55. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Neurology 1996, 46:907-911.
56. Magner W.J., Kazim A.L., Stewart C., Romano M.A., Catalano G., Grande C., Keiser N., Santaniello F., Tomasi T.B. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J. Immunol. 2000, 165:7017-7024.
57. Martello G., Rosato A., Ferrari F., Manfrin A., Cordenonsi M., Dupont S., Enzo E., Guzzardo V., Rondina M., Spruce T., Parenti A.R., Daidone M.G., Bicciato S., Piccolo S. A MicroRNA targeting dicer for metastasis control. Cell 2010, 141:1195-1207.
58. Martin E.C., Elliott S., Rhodes L.V., Antoon J.W., Fewell C., Zhu Y., Driver J.L., Jodari-Karimi M., Taylor C.W., Flemington E.K., Beckman B.S., Collins-Burow B.M., Burow M.E. Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells. Mol. Carcinog. 2014, 53:38-48.
59. Martinelli-Boneschi F., Fenoglio C., Brambilla P., Sorosina M., Giacalone G., Esposito F., Serpente M., Cantoni C., Ridolfi E., Rodegher M., Moiola L., Colombo B., De Riz M., Martinelli V., Scarpini E., Comi G., Galimberti D. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci. Lett. 2012, 508:4-8.
60. Mockenhaupt S., Schürmann N., Grimm D. When cellular networks run out of control: global dysregulation of the RNAi machinery in human pathology and therapy. Prog. Mol. Biol. Transl. Sci. 2011, 102:165-242.
61. Mushtaq G., Greig N.H., Anwar F., Zamzami M.A., Choudhry H., Shaik M.M., Tamargo I.A., Kamal M.A. miRNAs as circulating biomarkers for Alzheimer's Disease and Parkinson's Disease. Med. Chem. 2016, (Oct 30. Epub ahead of print).
62. Oak S.R., Murray L., Herath A., Sleeman M., Anderson I., Joshi A.D., Coelho A.L., Flaherty K.R., Toews G.B., Knight D., Martinez F.J., Hogaboam C.M. A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS ONE 2011, 6.
63. O'Connell R.M., Rao D.S., Baltimore D. microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 2012, 30:295-312.
64. Otaegui D., Baranzini S.E., Armañanzas R., Calvo B., Munoz-Culla M., Khankhanian P., Inza I., Lozano J.A., Castillo-Trivino T., Asensio A., Olaskoaga J., Lopez de Munain A. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS ONE 2009, 4:1-9.
65. Pang X., Hogan E.M., Casserly A., Gao G., Gardner P.D., Tapper A.R. Dicer expression is essential for adult midbrain dopaminergic neuron maintenance and survival. Mol. Cell. Neurosci. 2014, 58:22-28.
66. Reijerkerk A., Lopez-Ramirez M.A., van het Hof B., Drexhage J.A., Kamphuis W.W., Kooij G., Vos J.B., van der Pouw Kraan T.C., Horrevoets A.J., Prat A., Romero I.A., de Vries H.E. MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis. J. Neurosci. 2013, 33:6857-6863.
67. Robinson M., McCarthy D., Smyth G. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140.
68. Rottiers V., Näär A.M. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell. Biol. 2012, 13:239-250.
69. Rupaimoole R., Han H.D., Lopez-Berestein G., Sood A.K. MicroRNA therapeutics: principles, expectations, and challenges. Chin. J. Cancer. 2011, 30:368-370.
70. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
71. Serana F., Imberti L., Amato M.P., Comi G., Gasperini C., Ghezzi A., Martinelli V., Provinciali L., Rottoli M.R., Sotgiu S., Stecchi S., Vecchio M., Zaffaroni M., Cordioli C., Capra R. MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients. PLoS ONE 2014, 9.
72. Sharma H., Estep M., Birerdinc A., Afendy A., Moazzez A., Elariny H., Goodman Z., Chandhoke V., Baranova A., Younossi Z.M. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2013, 28:1410-1415.
73. Shin D., Shin J.Y., McManus M.T., Ptacek L.J., Fu Y.H. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann. Neurol. 2009, 66:843-857.
74. Sievers C., Meira M., Hoffmann F., Fontoura P., Kappos L., Lindberg R.L. Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clin. Immunol. 2012, 144:70-79.
75. Singh S., Bevan S.C., Patil K., Newton D.C., Marsden P.A. Extensive variation in the 5'-UTR of Dicer mRNAs influences translational efficiency. Biochem. Biophys. Res. Commun. 2005, 335:643-650.
76. Singh R.P., Massachi I., Manickavel S., Singh S., Rao N.P., Hasan S., Mc Curdy D.K., Sharma S., Wong D., Hahn B.H., Rehimi H. The role of miRNA in inflammation and autoimmunity. Autoimmun. Rev. 2013, 12:1160-1165.
77. Søndergaard H.B., Hesse D., Krakauer M., Sorensen P.S., Sellebjerg F. Differential microRNA expression in blood in multiple sclerosis. Mult. Scler. 2013, 19:1849-1857.
78. Stappert L., Borghese L., Roese-Koerner B., Weinhold S., Koch P., Terstegge S., Uhrberg M., Wernet P., Brustle O. MicroRNA-based promotion of human neuronal differentiation and subtype specification. PLoS ONE 2013, 8.
79. Tan J.Y., Marques A.C. The miRNA-mediated cross-talk between transcripts provides a novel layer of posttranscriptional regulation. Adv. Genet. 2014, 85:149-199.
80. Tokumaru S., Suzuki M., Yamada H., Nagino M., Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008, 29:2073-2077.
81. Vosslamber S., van Baarsen L.G., Verweij C.L. Pharmacogenomics of IFN-beta in multiple sclerosis: towards a personalized medicine approach. Pharmacogenomics 2009, 10:97-108.
82. Waschbisch A., Atiya M., Linker R.A., Potapov S., Schwab S., Derfuss T. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS ONE 2011, 6.
83. Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., Galas D.J., Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56:1733-1741.
84. Weinstock-Guttman B., Bhasi K., Badgett D., Tamano-Blanco M., Minhas M., Feichter J., Patrick K., Munschauer F., Bakshi R., Ramanathan M. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: relationships to 5-year clinical outcomes in multiple sclerosis patients. J. Neuroimmunol. 2008, 205:113-125.
85. Wiesen J.L., Tomasi T.B. Dicer is regulated by cellular stresses and interferons. Mol. Immunol. 2009, 46:1222-1228.
86. Winter J., Diederichs S. Argonaute proteins regulate microRNA stability: Increased microRNA abundance by Argonaute proteins is due to microRNA stabilization. RNA Biol. 2011, 8:1149-1157.
87. Xiong R., Wang Z., Zhao Z., Li H., Chen W., Zhang B., Wang L., Wu L., Li W., Ding J., Chen S. MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegeneration. Neurobiol. Aging 2014, 35:705-714.
88. Zhang J., Zhao H., Gao Y., Zhang W. Secretory miRNAs as novel cancer biomarkers. Biochim. Biophys. Acta 2012, 1826:32-43.